What is a cluster headache?
Cluster headache is one of the most severe forms of headache described in neurology. It is a primary headache disorder characterised by sudden, extremely intense pain on one side of the head, most often localised around the eye, behind the eye or in the temple. The pain usually lasts from 15 minutes to 3 hours and may recur in so-called “clusters” — repeated attacks occurring at similar times of day or night over weeks or months. For an overview of diagnostic criteria, see cluster headache – Wikipedia.
Cluster headaches are considered rare and occur more frequently in men than in women, typically beginning between 30 and 40 years of age. Between active periods, symptoms may completely disappear (remission). In addition to the excruciating pain, patients may experience redness, swelling or tearing of the eyes, sweating, sensitivity to light, nasal congestion, facial flushing, and strong emotional reactions such as anxiety or agitation. The exact cause is not fully understood, but research points to dysregulation in the hypothalamus — the brain region that helps regulate our internal biological clock and circadian rhythms.
What are the symptoms of cluster headache?
Cluster headache is a primary disorder — it is not usually a symptom of another disease, although serious conditions should always be ruled out by a physician. A typical cluster headache attack has several characteristic features:
- pain appears suddenly, without warning or aura,
- the pain is sharp, stabbing, throbbing, often described as unbearable,
- it usually affects one side of the head, involving the eye area and temple, and may radiate to the teeth, cheek, jaw or occiput,
- attacks occur in series (clusters) — there may be from 1 to 8 attacks per day,
- each attack lasts from 15 minutes to 3 hours,
- attacks tend to occur at specific times (e.g. shortly after falling asleep, at night or early morning),
- seasons such as spring or autumn may be associated with increased frequency,
- between attacks, patients usually feel well, but are often exhausted from pain and sleep disruption,
- after an active period, a phase of remission can last months or even years.
Symptoms typically appear on the same side of the face as the pain and may include:
- red, bloodshot eye,
- tearing,
- constricted pupil,
- facial swelling,
- drooping eyelid,
- facial sweating and flushing,
- irritation of the nasal mucosa, watery nasal discharge or blockage on one side.
Many patients are unable to sit or lie still during an attack and tend to pace, rock back and forth or press their head with their hands. Symptoms can be accompanied by:
- strong anxiety,
- psychomotor agitation,
- irritability,
- anger or aggression,
- after the attack: exhaustion and sometimes low mood, anxiety or depressive symptoms. You can read more about mood disorders in our article psychedelics in the treatment of depression (educational context only).
What is the difference between a cluster headache and a migraine?
Similarities between migraine and cluster headache
- both are primary headache disorders (not secondary to another condition in most cases),
- both have paroxysmal, episodic attacks,
- pain is often unilateral (on one side of the head), though migraine may also be bilateral,
- pain is intense, throbbing or pounding,
- patients may experience sensitivity to sound and light,
- strong smells can sometimes trigger or worsen pain.
Differences between cluster headache and migraine
- in migraine, nausea and vomiting are more common than in cluster headache,
- migraine often worsens with physical activity, and sufferers usually prefer to lie still in a dark room, whereas people with cluster headaches are often restless and unable to stay in one position,
- migraine has a well-described neurovascular component; cluster headache is more strongly linked to hypothalamic dysregulation and autonomic symptoms,
- migraine pain can move to different parts of the head, while cluster pain typically remains localised to the same side and region,
- migraine attacks are frequently associated with triggers such as stress, certain foods, alcohol or hormonal changes; cluster headache has a more rhythmic pattern, although alcohol can sometimes worsen cluster episodes during an active period,
- migraine attacks usually last from 4 to 72 hours, whereas cluster attacks typically last from 15 minutes to 3 hours but can recur many times during a day,
- migraine is more common in women; cluster headache is more common in men.
How common are cluster attacks? Typical pattern
Cluster headache often follows a cyclical pattern. Attacks may occur daily over a period of several weeks to several months (typically 4–12 weeks). This is followed by a remission phase, after which cluster periods may reappear. Many patients notice that attacks occur at remarkably similar times of day and often in particular seasons (spring or autumn). For some, the disorder is long-term and can recur throughout life, which significantly affects quality of life and emotional wellbeing.
Causes of cluster headache
The exact cause of cluster headache is still unknown. Studies suggest that dysfunction in the hypothalamus — a brain region involved in regulating circadian rhythms, hormones and autonomic functions — plays a central role. Risk is higher in people who smoke and in those with a family history of cluster headache, although a clear genetic pattern has not been fully confirmed. Attacks may be triggered or intensified by alcohol, strong odours (e.g. solvents, petrol, paint, perfume) or certain medications such as nitroglycerin used in heart disease. It is important to discuss potential triggers and treatment options with a neurologist.
How is cluster headache diagnosed?
Diagnosing cluster headache can be challenging. There is no single test that confirms the condition, so diagnosis is based on a detailed medical history, symptom description and sometimes imaging studies to exclude other causes. A headache diary — recording the date, time, duration and intensity of attacks, as well as potential triggers — can be very helpful for both patients and doctors. Misdiagnosis is unfortunately common, and many individuals are initially referred to dentists, ENT specialists or psychologists. As a result, years may pass before an accurate diagnosis is made. If you suspect that you may have cluster headaches, always consult a qualified healthcare professional.
Treatment options for cluster headache
Cluster headache is not usually life-threatening, but the pain can be so intense that some patients describe it as worse than childbirth. In severe cases, thoughts of self-harm may occur — this always requires urgent medical and psychological help. Current treatments aim primarily to shorten attacks, reduce their frequency and extend remission periods. They must always be chosen and monitored by a doctor.
Medication
Standard over-the-counter painkillers (such as paracetamol alone) are generally too slow or weak to relieve cluster attacks. In acute episodes, doctors may use:
- triptan nasal sprays or injections (prescription medicines),
- high-flow oxygen therapy (inhalations for about 15–30 minutes under medical guidance).
To help prevent attacks, neurologists may prescribe calcium channel blockers (such as verapamil), glucocorticoids (short-term, carefully monitored), or other agents like lithium carbonate in selected cases. These medicines can have significant side effects, so they must only be used under specialist supervision.
Transcutaneous vagus nerve stimulation (tVNS)
Transcutaneous vagus nerve stimulation (tVNS) is a technique that uses a medical device to deliver small electrical impulses to branches of the vagus nerve. Some studies suggest it may help reduce pain intensity and the frequency of cluster attacks. It is considered an adjunctive, specialist method — not a self-treatment — and should only be used within medical protocols.
Implanted stimulation devices
In very severe, treatment-resistant cases, an implantable neurostimulation device placed in the facial region can be considered. It delivers controlled electrical impulses to structures involved in pain transmission and autonomic regulation. This invasive option is typically reserved for highly selected patients in specialised centres. More information can be found in professional guidelines, for example on the website of the UK National Institute for Health and Care Excellence (NICE).
Experimental approaches with psychedelics (research context only)
Because traditional therapies do not always provide satisfactory relief and may cause side effects, some researchers have become interested in whether certain psychedelic substances (such as LSD or psilocybin) could influence the course of cluster headache. Small observational studies and patient reports suggest that these substances might interrupt cluster periods or prolong remission in some individuals. However, the available data are limited, not based on large controlled trials, and often involve self-medication outside legal and medical frameworks.
For example, a 2006 observational study published in the journal Neurology analysed a group of patients who had used LSD or psilocybin in an attempt to relieve cluster headaches. Many reported reduced frequency or intensity of attacks, and some described longer remission periods. However, because these substances are illegal in many countries (including Poland), participants exposed themselves to legal risks and potential health dangers. The study design does not allow firm conclusions about safety or efficacy, and the authors themselves emphasised the need for controlled clinical research, not self-experimentation.
More recently, interest in so-called microdosing — very small doses of psychedelics taken at intervals — has grown in public discourse. From a scientific perspective, this remains an experimental area. Some people claim improvements in mood or pain, but robust clinical evidence is still lacking, and microdosing may carry legal and health risks. You can read a broader educational overview in our article psilocybin microdosing – what you need to know, which does not constitute medical advice.
We strongly advise against self-treatment with illegal substances. Any potential future therapeutic use of psychedelics should take place exclusively in properly designed clinical trials or strictly regulated medical settings, where safety, dosing and monitoring are ensured by a professional team.
Important safety note
The above article is for informational and educational purposes only and does not replace a consultation with a doctor or another qualified healthcare professional. If you experience severe headaches, suicidal thoughts or symptoms suggesting a serious condition, seek immediate medical help.
The content on the psychodelicroom.pl website is research-oriented and often refers to ongoing or historical scientific work. We do not encourage the use of any psychoactive substances. All such substances can carry serious risks and should never be used outside legal and medical frameworks. In particular, we advise against cultivating mushrooms from growkits in countries where it is illegal — including Poland — because this may involve criminal liability. Growkits sold in our store are intended exclusively for research and collection purposes, and we recommend disposing of them within 72 hours of receipt in accordance with local law.
Selected sources and further reading
For more information on cluster headaches and current treatment guidelines, see:
Log in with Facebook
Log in with Google